[1]Kaplan MM,Gershwin ME. Primary biliary cirrhosis[J]. N Engl J Med,2005,353(12):1261-1273.[2]Selmi C,Bowlus CL,Gershwin ME,et al. Primary biliary cirrhosis[J]. Lancet,2011,377 (9777):1600-1609.[3]姜小华,傅青春,孙建文,等. AMA-M2抗体阳性原发性胆汁性肝硬化患者的实验室指标特征分析[J]. 肝脏,2010,15(2):84-86.[4]Yoshimura A,Naka T,Kubo M. SOCS proteins,cytokine signalling and immune regulation[J]. Nat Rev Immunol,2007,7(6):454-465. [5]Tamiya T,Kashiwagi I,Takahashi R,et al. Suppressors of cytokine signaling (SOCS) proteins and JAK/STAT pathways: regulation of T-cell inflammation by SOCS1 and SOCS3[J]. Arterioscler Thromb Vasc Biol,2011,31(5):980-985.[6]周运恒,马红霞,曹广亚,等. 原发性胆汁性肝硬化患者树突状细胞中细胞因子及其信号转导抑制分子的变化意义[J]. 中华检验医学杂志,2012,35(3):216-220.[7]Elkord E,Williams PE,Kynaston H,et al.Human monocyte isolation methods influence cytokine production from in vitro generated dendritic cells[J]. Immunology,2005,114(2):204-212.[8]Tsuda M,Ambrosini YM,Zhang W,et al. Fine phenotypic and functional characterization of effector cluster of differentiation 8 positive T cells in human patients with primary biliary cirrhosis[J]. Hepatology,2011,54(4):1293-1302.[9]Selmi C,Meroni PL,Gershwin ME. Primary biliary cirrhosis and Sjgren′s syndrome: autoimmune epithe-litis[J]. J Autoimmun,2012,39(1-2):34-42.[10]Gershwin ME,Mackay IR. The causes of primary biliary cirrhosis: convenient and inconvenient truths[J]. Hepatology,2008,47(2):737-745.[11]姜小华,仲人前,方晓云,等. 抗线粒体抗体M2抗原诱导小鼠原发性胆汁性肝硬化模型的建立[J]. 中华肝脏病杂志,2006,14(3):202-204.[12]Migliaccio C,Van de Water J,Ansari AA,et al. Heterogeneous response of antimitochondrial autoantibodies and bile duct apical staining monoclonal antibodies to pyruvate dehydrogenase complex E2: the molecule versus the mimic[J]. Hepatology,2001,33(4):792-801. [13]Rescigno M. Dendritic cells in tolerance induction for the treatment of autoimmune diseases [J]. Eur J Immunol,2010,40(8):2119-2123.[14]Hong B,Ren W,Song XT,et al. Human suppressor of cytokine signaling 1 controls immunostimulatory activity of monocyte-derived dendritic cells [J].Can-cer Res,2009,69(20):8076-8084.[15] Banchereau J,Briere F,Caux C,et al. Immunobiology of dendritic cells[J]. Annu Rev Immunol,2000,18: 767-811.[16]Mellman I,Steinman RM. Dendritic cells: specialized and regulated antigen processing machines[J]. Cell,2001,106(3): 255-258. [17]Hanada T,Tanaka K,Matsumura Y,et al. Induction of hyper TH1 cell-type immune responses by dendritic cells lacking the suppressor of cytokine signaling-1 gene[J]. J Immunol,2005,174(7):4325-4332.[18]Kinjyo I,Hanada T,Inagaki-Ohara K,et al. SOCS1/JAB is a negative regulator of LPS-induced macrophage activation[J]. Immunity,2002,17(5):583-591.[19]Berns K,Hijmans EM,Mullenders J,et al. A large-scale RNAi screen in human cells identifies new components of the p53 pathway[J]. Nature,2004,428(6981):431-437.[20]Evel-Kabler K,Song XT,Aldrich M,et al. SOCS1 restricts dendritic cells′ability to break self tolerance and induce antitumor immunity by regulating IL-12 production and signaling [J]. J Clin Invest,2006,116(1): 90-100. [21]Nagano T,Yamamoto K,Matsumoto S,et al. Cytokine profile in the liver of primary biliary cirrhosis [J]. J Clin Immunol,1999,19(6):422-427. [22]Jackson SH,Yu CR,Mahdi RM,et aL. Dendritic cell maturation requires STAT1 and is under feedback regulation by suppressors of cytokine signaling[J]. J Immunol,2004,172(4):2307-2315.[23]Mujtaba MG,Flowers LO,Patel CB,et al. Treatment of mice with the suppressor of cytokine signaling-1 mimetic peptide,tyrosine kinase inhibitor peptide,prevents development of the acute form of experimental allergic encephalomyelitis and induces stable remission in the chronic relapsing/remitting form[J]. J Immunol,2005,175(8):5077-5086.[24]Chen XP,Losman JA,Cowan S,et al. Pim serine/threonine kinases regulate the stability of Socs-1 protein[J]. Proc Natl Acad Sci USA,2002,99(4): 2175-2180.